Invention Grant
- Patent Title: Compounds which modulate the CB2 receptor
- Patent Title (中): 调节CB2受体的化合物
-
Application No.: US13521246Application Date: 2011-01-11
-
Publication No.: US09315454B2Publication Date: 2016-04-19
- Inventor: Alessandra Bartolozzi , Angela Berry , Doris Riether , Monika Ermann , James Edward Jenkins , Innocent Mushi
- Applicant: Alessandra Bartolozzi , Angela Berry , Doris Riether , Monika Ermann , James Edward Jenkins , Innocent Mushi
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Atabak R. Royaee
- International Application: PCT/US2011/020767 WO 20110111
- International Announcement: WO2011/088015 WO 20110721
- Main IPC: C07C317/06
- IPC: C07C317/06 ; A61K31/165 ; C07C323/41 ; C07C317/44 ; C07D211/54 ; C07D213/40 ; C07D261/08 ; C07D265/30 ; C07D295/185 ; C07D295/205 ; C07D309/04 ; C07D333/20 ; C07D333/38 ; C07D413/12
Abstract:
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Public/Granted literature
- US20120316173A1 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Public/Granted day:2012-12-13
Information query
